Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer

Figure 1

Estrogen treatment inhibits OGG1 expression. (A) Real-time PCR data are presented to show expression of OGG1 mRNA in mammary tumors and in mammary tissues of rats treated with E2 for 7 and 240 days. These data are reported as an average of fold change values obtained from at least 5 different animals ± SEM, compared to respective age-matched control mammary tissues. (B) OGG1 mRNA expression levels in MCF-10A and T47D cells treated with E2 (50 nM) for 6 and 48 h, respectively, presented as fold change versus time-matched vehicle-treated cells. OGG1 mRNA expression data was normalized to cyclophilin as an internal control. These data are reported as an average of values obtained from at least 5 different samples ± SEM. (C) Representative western blots for OGG1 protein expression in MCF-10A and T47D cells treated with E2 (50 nM) for 12 and 48 h, respectively. The bar graphs represent fold change in OGG1 protein expression (mean ± SEM), compared to time-matched vehicle-treated cells. ‘*’ indicates p value <0.05 compared to respective age- or time-matched control samples. (D) Representative western blot for OGG1 protein expression in different tissues of female ACI rats treated with E2 for 240 days as described in “Methods” section.

Back to article page
\